Loading...
Betacellulin drives therapy resistance in glioblastoma
BACKGROUND: The transcription factor signal transducer and activator of transcription 3 (STAT3) drives progression in glioblastoma (GBM), suggesting STAT3 as a therapeutic target. Surprisingly however, GBM cells generally show primary resistance to STAT3 blockade. METHODS: Human glioblastoma cell li...
Na minha lista:
| Udgivet i: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7158663/ https://ncbi.nlm.nih.gov/pubmed/31678994 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz206 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|